Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tirzepatide (Mounjaro/Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist that produces even greater weight loss than Semaglutide (average 20-22% of body weight)
Looking Ahead: Sustainable Supply The current scramble to increase GLP-1 manufacturing capacity is a testament to the transformative potential of these drugs
Who Should Avoid It Combined contraindications of all four components
Patient retention, self-injection hesitation hinder widespread GLP-1 drug usage
Gao Q, et al
GLP-1 agonists which include semaglutide medications such as Wegovy and Ozempic are a class of medications that mimic the GLP-1 hormone to help treat diabetes and obesity
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
